Douglas Holtzman - 31 May 2022 Form 5 Insider Report for Icosavax, Inc.

Role
Chief Scientific Officer
Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
31 May 2022
Net transactions value
+$9,619
Form type
5
Filing time
14 Feb 2023, 16:15:02 UTC
Previous filing
14 Feb 2022
Next filing
02 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICVX Common Stock Award $9,619 +1,667 +0.57% $5.77 294,925 31 May 2022 Direct F1
holding ICVX Common Stock 2,792 31 May 2022 By Stanley Holtzman F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2022 by the Reporting person in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c).
F2 Douglas Holtzman, Ph.D. holds power-of-attorney (POA) over the shares owned by Stanley Holtzman. As POA, Dr. Holtzman holds voting and dispositive control over such shares. Dr. Holtzman disclaims beneficial ownership of the shares over which he has POA except to the extent of any pecuniary interest therein.